ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Combined Liver-Kidney Transplantation in Children: Long-Term Follow-Up in 27 Children.

M. Kemper,1 B. Nashan,2 L. Fischer,2 F. Brinkert.1

1Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2Hepatobiliary and Transplantation Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Meeting: 2016 American Transplant Congress

Abstract number: D219

Keywords: Kidney/liver transplantation, Metabolic disease, Outcome, Polycystic kidney disease

Session Information

Date: Tuesday, June 14, 2016

Session Name: Poster Session D: Pediatric Liver Transplantation

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Outcomes of Combined Liver-Kidney Transplantation in Children: Analysis of the SRTR Registry
  • Clinical Results of Combined and Sequential Liver-Kidney Transplantation: A Single Center Experience

Combined liver and kidney transplantation (CLKT) is an important treatment option for patients suffering from diseases like autosomal recessive polycystic kidney disease (ARPKD) or primary hyperoxaluria type 1 (PH1). To examine the long-term outcome of this cohort all children undergoing CLKT at our centre between 1998 and 2014 were included in this retrospective analysis. 29 CLKT have been performed in 27 patients, suffering from PH1 (n= 15), ARPKD (n=11) and nephronophtisis type 11 (n=1). Median Age at tranplantation was 8.2 (1.3- 15.9) years with a body weight of 25 (9-53) kg. After a median follow-up of 6 (0.6- 10.8) years, patient-survival is 93% and liver and kidney graft survival 76 % and 79%, respectively. Currently liver function tests are in the normal range (median AST, ALT and INR 27 U/l, 23 U/l, 1.04). Three of the PH1 patients are on dialysis again at present; the median eGFR of the other patients is 72 (27- 132) ml/min/1,73m[sup2]. 6 out of 11 PH1 patients with functional renal grafts still have pathological range hyperoxaluria of > 0.45 mmol/1.73m[sup2] day. 4 of the PH1 patients have visual loss due to retinal oxalate deposition which did not improve after transplantation. The regression analysis yielded a significant impact on the long- term eGFR by analysing the eGFR baseline (p< 0.001), the period of dialysis before TX (p= 0.04) and the donor/recipient age ratio (p=0.019). In conclusion our results indicate that CLKT is a valuable and important option in the treatment of PH1 and ARPKD.

CITATION INFORMATION: Kemper M, Nashan B, Fischer L, Brinkert F. Combined Liver-Kidney Transplantation in Children: Long-Term Follow-Up in 27 Children. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kemper M, Nashan B, Fischer L, Brinkert F. Combined Liver-Kidney Transplantation in Children: Long-Term Follow-Up in 27 Children. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/combined-liver-kidney-transplantation-in-children-long-term-follow-up-in-27-children/. Accessed February 28, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.